High blood sugar powers an experimental implant that helps improve glucose control in diabetes
AI Image

High blood sugar powers an experimental implant that helps improve glucose control in diabetes

Medical Xpress • • health

Key Points:

  • Researchers have developed NeuroAxis, an experimental implant powered by a glucose fuel cell that monitors blood sugar levels in real time and stimulates the vagus nerve to regulate metabolism and inflammation in diabetes patients.
  • Unlike existing electroceuticals, NeuroAxis harvests energy directly from glucose in surrounding tissue, eliminating the need for external batteries or wireless charging, and delivers electrical pulses when blood sugar remains high.
  • In rat models of type 1 and type 2 diabetes, the implant promoted pancreatic beta-cell growth, improved insulin sensitivity, normalized blood sugar levels, and reduced inflammation and fat accumulation, with effects lasting weeks after stimulation ceased.
  • The device functions as an artificial neuroimmune axis, restoring communication between the nervous, immune, and metabolic systems that is often disrupted in diabetes, potentially offering a novel approach to treating metabolic disorders.
  • Researchers note that further improvements in the biofuel cell's stability and threshold settings are needed before NeuroAxis can be used for long-term treatment.

Trending Business

Trending Technology

Trending Health